• Dual FLT3/CHK1 PROTACs to Overcome Resistance in AML Therapy

  2026-07-28

  The referenced study introduces dual FLT3/CHK1-targeting PROTACs that degrade both kinases to address adaptive and acquired resistance in acute myeloid leukemia (AML). This approach offers a mechanistically distinct strategy compared to traditional inhibitors, highlighting the potential for overcoming clinical limitations of monotherapies.

• PBS Liposomes: Essential Controls for Macrophage Depletion S

  2026-07-28

  PBS Liposomes provide an inert, reproducible control for in vivo and in vitro macrophage depletion experiments—crucial for distinguishing true immunological effects from baseline responses. Leveraging recent advances in structural biology and optimized protocols, these phosphate-buffered saline liposomes help researchers achieve rigor and clarity in immune modulation assays.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Apoptosis As

  2026-07-27

  Q-VD(OMe)-OPh delivers reliable, non-toxic, and broad-spectrum caspase inhibition, empowering apoptosis research across cancer, neuroprotection, and drug resistance models. Its unique potency and minimal off-target effects streamline complex experimental workflows and yield reproducible, high-confidence results.

• N1-Methylpseudo-UTP: Advancing mRNA Therapeutics for Localiz

  2026-07-27

  Translational researchers face unique challenges in developing effective mRNA therapeutics for localized disease. This article provides mechanistic analysis and strategic recommendations for leveraging N1-Methyl-Pseudouridine-5'-Triphosphate in the creation of robust, stable, and translationally efficient mRNA constructs—highlighting its impact on intravesical mRNA delivery in bladder cancer, competitive workflow insights, and a forward-looking vision for RNA-based therapies. Contextual product recommendations and evidence from recent peer-reviewed studies are integrated to guide next-generation protocol optimization.

• MitMAB in Organoid Models: Precision for Endocytosis Researc

  2026-07-26

  MitMAB empowers high-fidelity dissection of endocytosis and membrane trafficking in advanced organoid and intestinal stem cell models, allowing precise mechanistic interrogation of vesicle uptake. APExBIO’s high-purity inhibitor sets a reproducible benchmark for intracellular trafficking research and troubleshooting complex cellular uptake assays.

• Praeruptorin A Suppresses NF-κB Pathway in Poly(I:C)-Activat

  2026-07-25

  The referenced study demonstrates that Praeruptorin A, a natural coumarin, inhibits NF-κB pathway activation and downstream inflammatory gene expression in poly(I:C)-induced RAW264.7 macrophages. These mechanistic insights advance models for inflammation assay design and highlight new targets for antiviral and immunomodulatory drug discovery.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Practical Use

  2026-07-24

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) provides broad-spectrum protection against proteolytic degradation during protein extraction workflows, while remaining compatible with cation-sensitive applications. It should not be used in workflows that require chelation of divalent cations, as it is EDTA-free.

• MMP-2/9 Inhibition Preserves BBB and Cognition in Arsenic-Tr

  2026-07-24

  This study elucidates how chronic sodium arsenite exposure impairs learning and memory in male mice through MMP-2 and MMP-9-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. Importantly, the research demonstrates that doxycycline hyclate, a matrix metalloproteinases inhibitor, can preserve BBB integrity and mitigate arsenic-induced cognitive deficits, highlighting potential mechanistic targets for neurotoxicity intervention.

• Acifran: Structural Insights and Practical Advances in Lipid

  2026-07-23

  Explore Acifran's role as a selective HM74A/GPR109A and GPR109B agonist in lipid metabolism research. This article delivers unique, structure-based assay guidance and experimental strategies, revealing how new cryo-EM insights directly impact practical study design.

• TRPV1+ Somatosensory Nerve Stimulation Suppresses Inflammati

  2026-07-23

  Song et al. (2025) demonstrate that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape triggers a somato-autonomic reflex, resulting in rapid suppression of systemic inflammation. This mechanistic insight reveals a neural circuit linking sensory nerve activation to immune modulation, with implications for translational inflammation research.

• PXR Activation Promotes Liver Regeneration and CYP Induction

  2026-07-22

  This study reveals that activation of the pregnane X receptor (PXR) in rats not only triggers liver enlargement and regeneration but also upregulates the metabolic activity of key cytochrome P450 enzymes (CYP3A1/2 and CYP2C6/11). The findings advance understanding of hepatic adaptation, with implications for drug metabolism research and experimental modeling of liver regeneration.

• Elucidating Metabolite Regulation of TET2 via Biochemical an

  2026-07-22

  The referenced protocol advances methods for identifying metabolite binding and regulatory mechanisms of the epigenetic enzyme TET2. By integrating biochemical assays with saturation transfer difference NMR, the study enables systematic validation of both activators and inhibitors, informing the interplay between metabolism and epigenetic regulation.

• Protein Corona Impact on Nanoparticle Delivery and Expressio

  2026-07-21

  Elizabeth Voke's 2025 dissertation systematically investigates how protein corona formation on nanoparticles, particularly lipid nanoparticles (LNPs), influences their cellular uptake and mRNA delivery performance. The study's robust proteomics workflow reveals that corona protein composition—rather than particle uptake alone—modulates intracellular trafficking and transgene expression, with significant implications for mRNA-based therapeutic design.

• Lanabecestat (AZD3293): Strategic BACE1 Inhibition for AD Re

  2026-07-21

  Explore the mechanistic rationale and translational strategies for using Lanabecestat (AZD3293) as a precision BACE1 inhibitor in Alzheimer's disease research. This thought-leadership article synthesizes breakthrough findings on synaptic-sparing amyloid-beta reduction, protocol guidance, and the evolving landscape of preclinical and clinical development, offering actionable insight for translational neurodegeneration researchers.

• A-769662: Redefining AMPK Activation and Energy Stress Modul

  2026-07-20

  Explore how A-769662, a potent AMPK activator, unveils new insights into cellular energy regulation and autophagy control. This article delivers a unique, deep scientific analysis grounded in recent paradigm-shifting research.

16801 records 1/1121 page Next 12345 下5页 Last page